Wockhardt gets DGCI approval for 2 new antibiotics
Posted by
www.biotecnika.org
"DCGI (Drug Controller General of India) has approved Wockhardt's two
new antibiotics, EMROK (IV) and EMROK 0 (Oral), for acute bacterial
skin and skin structure infections including diabetic foot infections
and concurrent bacteraemia...," the drug firm said. The new drug will
target superbug like Methicillin resistant Staphylococcus aureus.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/wockhardt-gets-dgci-approval-for-2-new-antibiotics/articleshow/73293398.cms
Subscribe to:
Post Comments (Atom)
Post a Comment